Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$119.09−1.18 (-0.98%)
Close on Nov 17, 2026Market cap $24.27BP/E 63.3Yield –
Incyte gross margin
Gross margin is gross profit as a percentage of revenue.
Incyte's gross margin for the twelve months ending Sep 30, 2026 was 92.7%. For fiscal 2025 it was 92.8%, against 92.6% the year before. The highest annual figure on record is 99.9% in fiscal 2012.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 92.8% | +0.1 |
| FY2024 | Dec 31, 2024 | 92.6% | −0.5 |
| FY2023 | Dec 31, 2023 | 93.1% | −0.8 |
| FY2022 | Dec 31, 2022 | 93.9% | −1.0 |
| FY2021 | Dec 31, 2021 | 94.9% | −0.1 |
| FY2020 | Dec 31, 2020 | 95.1% | +0.4 |
| FY2019 | Dec 31, 2019 | 94.7% | −0.3 |
| FY2018 | Dec 31, 2018 | 95.0% | +0.2 |
| FY2017 | Dec 31, 2017 | 94.8% | +0.1 |
| FY2016 | Dec 31, 2016 | 94.7% | −1.7 |
| FY2015 | Dec 31, 2015 | 96.4% | −3.0 |
| FY2014 | Dec 31, 2014 | 99.4% | −0.4 |
| FY2013 | Dec 31, 2013 | 99.8% | −0.1 |
| FY2012 | Dec 31, 2012 | 99.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 93.0% | +0.3 |
| Q2 FY2026 | Jun 30, 2026 | 93.7% | +0.2 |
| Q1 FY2026 | Mar 31, 2026 | 91.8% | −1.3 |
| Q4 FY2025 | Dec 31, 2025 | 92.0% | −0.5 |
| Q3 FY2025 | Sep 30, 2025 | 92.8% | +0.3 |
| Q2 FY2025 | Jun 30, 2025 | 93.5% | +0.9 |
| Q1 FY2025 | Mar 31, 2025 | 93.0% | −0.0 |
| Q4 FY2024 | Dec 31, 2024 | 92.5% | −0.6 |
| Q3 FY2024 | Sep 30, 2024 | 92.4% | −1.0 |
| Q2 FY2024 | Jun 30, 2024 | 92.7% | −0.2 |
| Q1 FY2024 | Mar 31, 2024 | 93.1% | +0.1 |
| Q4 FY2023 | Dec 31, 2023 | 93.1% | −0.5 |
| Q3 FY2023 | Sep 30, 2023 | 93.5% | +0.1 |
| Q2 FY2023 | Jun 30, 2023 | 92.8% | −1.6 |
| Q1 FY2023 | Mar 31, 2023 | 93.0% | −1.2 |
| Q4 FY2022 | Dec 31, 2022 | 93.6% | −1.3 |
| Q3 FY2022 | Sep 30, 2022 | 93.4% | −1.7 |
| Q2 FY2022 | Jun 30, 2022 | 94.4% | −0.2 |
| Q1 FY2022 | Mar 31, 2022 | 94.2% | −1.0 |
| Q4 FY2021 | Dec 31, 2021 | 94.9% | −0.5 |
| Q3 FY2021 | Sep 30, 2021 | 95.1% | +0.6 |
| Q2 FY2021 | Jun 30, 2021 | 94.6% | −0.5 |
| Q1 FY2021 | Mar 31, 2021 | 95.2% | −0.0 |
| Q4 FY2020 | Dec 31, 2020 | 95.4% | +1.0 |
| Q3 FY2020 | Sep 30, 2020 | 94.5% | −0.1 |
| Q2 FY2020 | Jun 30, 2020 | 95.2% | +0.7 |
| Q1 FY2020 | Mar 31, 2020 | 95.2% | −0.3 |
| Q4 FY2019 | Dec 31, 2019 | 94.4% | −0.6 |
| Q3 FY2019 | Sep 30, 2019 | 94.6% | +0.1 |
| Q2 FY2019 | Jun 30, 2019 | 94.5% | −0.8 |
| Q1 FY2019 | Mar 31, 2019 | 95.5% | +0.2 |
| Q4 FY2018 | Dec 31, 2018 | 95.0% | +0.0 |
| Q3 FY2018 | Sep 30, 2018 | 94.5% | +0.3 |
| Q2 FY2018 | Jun 30, 2018 | 95.2% | +1.4 |
| Q1 FY2018 | Mar 31, 2018 | 95.3% | −0.9 |
| Q4 FY2017 | Dec 31, 2017 | 95.0% | +1.0 |
| Q3 FY2017 | Sep 30, 2017 | 94.2% | – |
| Q2 FY2017 | Jun 30, 2017 | 93.8% | – |
| Q1 FY2017 | Mar 31, 2017 | 96.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 94.0% | – |
See a number that looks wrong?